|
Volumn 45, Issue 5, 2006, Pages 636-637
|
Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
ORNIDAZOLE;
PLACEBO;
ADULT;
AGED;
ANALYSIS OF VARIANCE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE DURATION;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG TOLERABILITY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HEADACHE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MORNING STIFFNESS;
NAUSEA;
PAIN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
XEROSTOMIA;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
ORNIDAZOLE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 33646180678
PISSN: 14620324
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/kel020 Document Type: Letter |
Times cited : (13)
|
References (10)
|